Protocol List

Protocol results based on your search.

Disease Site: Endocrine Diseases

Title Protocol Number Status
A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Assess the Safety and Efficacy of Exenatide Once Weekly in Adolescents with Type 2 Diabetes (D5551C00002) STUDY00000874 Open
Role of transcranial direct current stimulation in appetite and weight control, a prospective randomized study STUDY00000918 Open
Impact of Periodontal therapy on Patients with Diabetes: A Pilot Study STUDY00000962 Open
GLP-Receptor Agonist Therapy and Albuminuria in Patients with Type 2 Diabetes STUDY00001041 Open
Effect of Testosterone Replacement on Erythropoietin Stimulating agent use in End stage Renal Disease patients STUDY00001113 Open
A Phase 3 Study to Evaluate the Glucose Response of G-Pen (Glucagon Injection) in Pediatric Patients with Type 1 Diabetes STUDY00001200 Open
Title of research study: Mifepristone Effect and Action in Patients with Nonalcholic Fatty Liver Disease (MEAN) STUDY00001416 Not Open
A multicenter, phase 3, randomized, open-label, active-controlled, parallel-group trial investigating the safety, tolerability, and efficacy of TransCon hGH administered once a week versus standard daily hGH replacement therapy over 52 weeks in prepubertal children with growth hormone deficiency (GHD) (TransCon hGH CT-301) STUDY00001461 Open
A PHASE Ib, RANDOMIZED, BLINDED, PLACEBO CONTROLLED, MULTIPLE ASCENDINGDOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SUBCUTANEOUS BFKB8488A IN PATIENTS WITH TYPE 2 DIABETES MELLITUS STUDY00001615 Open